0000950170-24-003699.txt : 20240110
0000950170-24-003699.hdr.sgml : 20240110
20240110175645
ACCESSION NUMBER: 0000950170-24-003699
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240108
FILED AS OF DATE: 20240110
DATE AS OF CHANGE: 20240110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nabel Gary J.
CENTRAL INDEX KEY: 0001867450
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33528
FILM NUMBER: 24527522
MAIL ADDRESS:
STREET 1: C/O SIGA TECHNOLOGIES, INC.
STREET 2: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPKO HEALTH, INC.
CENTRAL INDEX KEY: 0000944809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 752402409
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 305-575-4181
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER COMPANY:
FORMER CONFORMED NAME: Opko Health, Inc.
DATE OF NAME CHANGE: 20070621
FORMER COMPANY:
FORMER CONFORMED NAME: eXegenics Inc
DATE OF NAME CHANGE: 20040505
FORMER COMPANY:
FORMER CONFORMED NAME: EXEGENICS INC
DATE OF NAME CHANGE: 20011114
4
1
ownership.xml
4
X0508
4
2024-01-08
0000944809
OPKO HEALTH, INC.
OPK
0001867450
Nabel Gary J.
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
MIAMI
FL
33137
true
true
false
false
Chief Innovation Officer
false
Common Stock
2024-01-08
4
P
false
108695
0.925
A
351442
I
See Footnote
Common Stock
2024-01-08
4
P
false
500
0.9178
A
500
I
By Spouse
Common Stock
2024-01-08
4
P
false
106989
0.9293
A
107489
I
By Spouse
Common Stock
263079
D
Common Stock
19912459
I
See Footnote
Common Stock
19912459
I
See Footnote
Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be dee admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Steven D. Rubin, Attorney-in-Fact
2024-01-10